Gland Pharma Limited — Updates, 10-08-2026: Press Release
10-08-2026 | 04:28 pm
10-08-2026 | 04:28 pm
Gland Pharma delivered record Q1FY27 revenue of ₹1,800.3 Cr (+20% YoY) and PAT of ₹317 Cr (+47% YoY). Growth driven by successful CDMO strategy, new product launches, and robust B2B demand. Strong pipeline and new partnerships underpin future expansion.
No comments yet. Be the first to comment!
